Tabares, Genara A.

HRN: 05-40-28  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2026
METRONIDAZOLE 500MG (TAB)
06/03/2026
06/09/2026
PO
500mgtab
TID
Amoebiasis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines